TrialThe Lancet. Infectious diseases2022

Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: a multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial.

Suman Kanungo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.